GMED
$57.84
Revenue | $745.34Mn |
Net Profits | $202.85Mn |
Net Profit Margins | 27.22% |
PE Ratio | 22.75 |
Globus Medical, Inc.’s revenue jumped 18.37% since last year same period to $745.34Mn in the Q2 2025. On a quarterly growth basis, Globus Medical, Inc. has generated 24.61% jump in its revenue since last 3-months.
Globus Medical, Inc.’s net profit jumped 538.68% since last year same period to $202.85Mn in the Q2 2025. On a quarterly growth basis, Globus Medical, Inc. has generated 168.81% jump in its net profits since last 3-months.
Globus Medical, Inc.’s net profit margin jumped 439.58% since last year same period to 27.22% in the Q2 2025. On a quarterly growth basis, Globus Medical, Inc. has generated 115.71% jump in its net profit margins since last 3-months.
Globus Medical, Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 22.75.
EPS Estimate Current Quarter | 0.77 |
EPS Estimate Current Year | 0.77 |
Globus Medical, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.77 - a 2.67% jump from last quarter’s estimates.
Globus Medical, Inc.’s earning per share (EPS) estimates for the current year stand at 0.77.
Earning Per Share (EPS) | 0 |
Globus Medical, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Globus Medical, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-08 | 0.74 | 0.68 | -8.11% |
2025-08-07 | 0.75 | 0.86 | 14.67% |
2025-11-04 | 0.77 | 0 | -100% |